Brief: Richter, Allergan extend Cariprazine agreement to Latin America
21/06/2019 07:23
June 21 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt
GDRB.BU:
RICHTER SAYS AMENDS EXISTING LICENSE AGREEMENT WITH ALLERGAN
PLC FOR CARIPRAZINE TO INCLUDE MAJOR MARKETS IN LATIN AMERICA
ALLERGAN WILL BE RESPONSIBLE FOR REGISTRATION OF PRODUCT IN
THE NEWLY LICENSED AREAS
Further company coverage: GDRB.BU
Source text: https://bet.hu/newkibdata/128248543/RCH190621ER01E.pdf
(Reporting by Krisztina Than)
((krisztina.than@thomsonreuters.com; +36 1 327 4745; Reuters
Messaging: krisztina.than.thomsonreuters.com@reuters.net))
Recent news on Richter Gedeon Vegyeszeti Gyar Nyrt
See all newsAI in Hungary could unlock productivity gains of €15 billion, McKinsey says
Brief: Hungary's Richter and Hetero announce cooperation for development of semaglutide injection
Brief: Hungary's Richter and Acrux agree to license transdermal Estradiol spray for Australia
Brief: Hungary's Richter Says 2026 Guidance Fully Reiterated High-Single-Digit Growth In Revenues And Clean EBIT (At Constant Exchange Rates)
Brief: Hungary's Richter says European Commission granted approval for Tuyory, its biosimilar to Tocilizumab